-
Speaker
List
Print
-
All Conference Hall No.1(2F) Conference Hall No.5-A(1F) Conference Hall No.5-B(1F) Conference Hall No.5-C(1F) Conference Hall No.5-D(1F) Conference Hall No.2-A(2F) Conference Hall No.2-B(2F) Conference Hall No.2-C(2F) Conference Hall No.2-AB(2F) Conference Hall No.3(Vascular care)(1F) Convention Hall No.2(2F) Conference Hall 201-A(2F) Conference Room 201-AB(2F) Conference Room 201-ABC(2F) Conference Room 201-BC(2F) Conference Room 201-D(2F) Conference Room 201-CD(2F) Coference Room No.307(3F) Conference Room No.308(3F) Conference Hall No.2-VIP-room-A(2F) Electronic Poster Machine:Conference Hall No.4(1F) Satellite Symposium
13:30-15:00
Arterial science and innovation(Simultaneous Interpretation )
Moderator: Shijie Xin China , Alan Dardik United States , Lianrui Guo China , John Fletcher Australia 主持: 辛世杰 China , Alan Dardik United States , 郭连瑞 China , John Fletcher Australia |
|||||
---|---|---|---|---|---|
NO./编号 | Time/时间 | Type/类型 | Subject/题目 | Speaker/讲者 | |
1 | 13:30-13:42 | Symposium |
Preclinical atherosclerosis as marker of multifocal atherosclerosis and predictor of future cardiovascular events |
Salvatore Novo Italy |
|
2 | 13:42-13:54 | Symposium |
Preliminary study of directional debulking devices plus drug-coated balloon for vertebral artery stenosis |
Lixing Qi 齐立行 China |
|
3 | 13:54-14:06 | Symposium |
Development of a new small calibre prosthetic vascular graft |
John Fletcher Australia |
|
4 | 14:06-14:18 | Symposium |
Preliminary clinical application of tissue-engineered small caliber vessels |
Zhu Tong 佟铸-重复数据 China |
|
5 | 14:18-14:30 | Symposium |
Stem cell therapy in PAOD |
Dong-ik Kim Korea |
|
6 | 14:30-14:42 | Symposium |
Phase II multicenter, randomized, double-blind, placebo-controlled clinical trial of the plasmid pUDK-HGF expressing human hepatocyte growth factor for critical limb ischemia |
Lixing Qi 齐立行 China |
|
7 | 14:42-14:54 | Symposium |
Efficacy and safety of plasmid DNA expressing isoforms of hepatocyte growth factor on pain and ulcer:A multicenter randomized double-blind, placebo-controlled Phase II study in patients with critical limb ischemia |
Lianrui Guo 郭连瑞 China |
|
8 | 14:54-15:00 |
Discussion |